Food groups intake of cirrhotic patients, comparison with the nutritional status and disease stage.
Child-Pugh score
food groups
hepatic cirrhosis
malnutrition
Journal
Gastroenterology and hepatology from bed to bench
ISSN: 2008-2258
Titre abrégé: Gastroenterol Hepatol Bed Bench
Pays: Iran
ID NLM: 101525875
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
19
9
2019
pubmed:
19
9
2019
medline:
19
9
2019
Statut:
ppublish
Résumé
The aim of this study was to determine the relation between different food groups intake, nutritional status of cirrhotic patient and the stage of the disease. Protein-energy malnutrition (PEM) is a common problem in cirrhotic patients. Food intake assessment is highly important in the investigation regarding the health-disease process. In this cross-sectional study, sixty eight ambulatory cirrhotic patients, with a mean age of 54 years, were included. In order to assess the stage of the disease and malnutrition status, Child-Pugh score and Subjective Global Assessment index were used respectively. Dietary intakes were assessed using a 168-item semi-quantitative validated food frequency questionnaire. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were computed, using logistic regression models. After adjustment for confounders, we found significant inverse relations between intakes of nuts (OR=0.140, CI=0.031-0.625) and olive (OR=0.212, CI=0.049-0.917) with severity of disease and boiled potatoes (OR=0.154, CI=0.040-0.592) and legumes (OR=0.090, CI=0.020-0.406) with malnutrition status. Inversely, solid fats (OR=3.324, CI=1.080-10.238) and mayonnaise (OR=5.215, CI=1.203-22.612) were positively associated with disease severity and malnutrition, respectively. These findings suggest that selection of healthy foods was negatively associated with severity of hepatic cirrhosis whereas unhealthy food groups had a positive relation with disease severity and malnutrition.
Sections du résumé
AIM
OBJECTIVE
The aim of this study was to determine the relation between different food groups intake, nutritional status of cirrhotic patient and the stage of the disease.
BACKGROUND
BACKGROUND
Protein-energy malnutrition (PEM) is a common problem in cirrhotic patients. Food intake assessment is highly important in the investigation regarding the health-disease process.
METHODS
METHODS
In this cross-sectional study, sixty eight ambulatory cirrhotic patients, with a mean age of 54 years, were included. In order to assess the stage of the disease and malnutrition status, Child-Pugh score and Subjective Global Assessment index were used respectively. Dietary intakes were assessed using a 168-item semi-quantitative validated food frequency questionnaire. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were computed, using logistic regression models.
RESULTS
RESULTS
After adjustment for confounders, we found significant inverse relations between intakes of nuts (OR=0.140, CI=0.031-0.625) and olive (OR=0.212, CI=0.049-0.917) with severity of disease and boiled potatoes (OR=0.154, CI=0.040-0.592) and legumes (OR=0.090, CI=0.020-0.406) with malnutrition status. Inversely, solid fats (OR=3.324, CI=1.080-10.238) and mayonnaise (OR=5.215, CI=1.203-22.612) were positively associated with disease severity and malnutrition, respectively.
CONCLUSION
CONCLUSIONS
These findings suggest that selection of healthy foods was negatively associated with severity of hepatic cirrhosis whereas unhealthy food groups had a positive relation with disease severity and malnutrition.
Types de publication
Journal Article
Langues
eng
Pagination
226-232Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Clin Nutr. 2005 Oct;24(5):751-9
pubmed: 16182039
Aliment Pharmacol Ther. 2006 Aug 15;24(4):563-72
pubmed: 16827812
Arq Gastroenterol. 2006 Oct-Dec;43(4):269-74
pubmed: 17406753
Public Health Nutr. 2010 May;13(5):654-62
pubmed: 19807937
Eur J Gastroenterol Hepatol. 2011 Nov;23(11):982-9
pubmed: 21971339
Clin Liver Dis. 2014 Feb;18(1):179-90
pubmed: 24274873
J Clin Exp Hepatol. 2014 Jun;4(2):141-50
pubmed: 25755550
World J Gastroenterol. 2015 Oct 7;21(37):10621-35
pubmed: 26457022
Curr Treat Options Gastroenterol. 2016 Jun;14(2):257-73
pubmed: 27023701
Phytother Res. 2016 Aug;30(8):1339-44
pubmed: 27151322
Arq Gastroenterol. 2016 Oct-Dec;53(4):250-256
pubmed: 27706455
Gastroenterol Hepatol (N Y). 2016 Aug;12(8):507-510
pubmed: 27917086
Gastroenterol Hepatol Bed Bench. 2016 Dec;9(Suppl1):S14-S22
pubmed: 28224023
Endocr Metab Immune Disord Drug Targets. 2018;18(1):75-84
pubmed: 29141573
J Clin Exp Hepatol. 2017 Dec;7(4):340-357
pubmed: 29234200
Gastroenterology. 1985 Sep;89(3):538-44
pubmed: 2991068
J Hepatol. 2019 Jan;70(1):172-193
pubmed: 30144956
JPEN J Parenter Enteral Nutr. 1987 Jan-Feb;11(1):8-13
pubmed: 3820522
Clin Sci (Lond). 1984 Jun;66(6):649-57
pubmed: 6327139
J Intern Med. 1993 May;233(5):385-92
pubmed: 8068051